Acutaas Chemicals Limited (NSE:ACUTAAS)
India · Delayed Price · Currency is INR | Market Cap | 330.78B +129.0% |
| Revenue (ttm) | 15.93B +45.2% |
| Net Income | 4.39B +96.1% |
| EPS | 53.38 +95.0% |
| Shares Out | 81.87M |
| PE Ratio | 75.68 |
| Forward PE | 56.65 |
| Dividend | 2.50 (0.06%) |
| Ex-Dividend Date | Sep 17, 2026 |
| Volume | 751,777 |
| Open | 3,947.00 |
| Previous Close | 3,916.90 |
| Day's Range | 3,902.20 - 4,120.00 |
| 52-Week Range | 1,570.00 - 4,120.00 |
| Beta | -0.11 |
| Analysts | Buy |
| Price Target | 3,744.11 (-7.33%) |
| Earnings Date | Nov 14, 2026 |
About Acutaas Chemicals
Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients, as well as new chemical entities. It also provides specialty chemicals, including photoresist chemicals for semiconductor applications; electrolyte additives for lithium battery cells; and parabens, methyl salicylate, and other commodity chemicals for cosmetics, agrochemicals, and fine chem... [Read more]
Financial Performance
In fiscal year 2026, Acutaas Chemicals's revenue was 13.39 billion, an increase of 33.02% compared to the previous year's 10.07 billion. Earnings were 3.56 billion, an increase of 124.46%.
Financial StatementsAnalyst Summary
According to 9 analysts, the average rating for ACUTAAS stock is "Buy." The 12-month stock price target is ₹3,744, which is a decrease of -7.33% from the latest price.
News
Acutaas Chemicals Transcript: Q2 26/27
Q2 revenue rose 42.7% YoY, with strong pharma and CDMO growth lifting margins. FY27 revenue growth guidance rose to ~30%, and CDMO targets advanced to INR 1,000 crore in FY27 and INR 2,000 crore by FY30.
Acutaas Chemicals Quarterly report: Q2 2027
Acutaas Chemicals has published its Q2 2027 quarterly earnings report on October 27, 2026.
Acutaas Chemicals Slides: Q2 2027
Acutaas Chemicals has posted slides in relation to its Q2 2027 quarterly earnings report, which was published on October 27, 2026.
Acutaas Chemicals Transcript: Q1 26/27
Q1 FY 2027 saw 59.1% YoY revenue growth, margin expansion, and strong demand in pharma intermediates and battery chemicals. New plants and product launches are set to drive further growth, with 25% revenue growth guidance and stable margins for FY 2027.
Acutaas Chemicals Quarterly report: Q1 2027
Acutaas Chemicals has published its Q1 2027 quarterly earnings report on July 24, 2026.
Acutaas Chemicals Slides: Q1 2027
Acutaas Chemicals has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on July 24, 2026.
Acutaas Chemicals Slides: Corporate presentation
Acutaas Chemicals has posted slides in relation to its latest quarterly earnings report, which was published on May 16, 2026.
Acutaas Chemicals Transcript: Q4 25/26
Record FY26 revenue and PAT driven by strong growth in pharma intermediates, specialty, and battery chemicals. FY27 guidance targets 25-28% revenue growth with stable margins, supported by robust order book and new product launches.
Acutaas Chemicals Quarterly report: Q4 2026
Acutaas Chemicals has published its Q4 2026 quarterly earnings report on April 30, 2026.
Acutaas Chemicals Slides: Q4 2026
Acutaas Chemicals has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on April 30, 2026.
Acutaas Chemicals Annual report: Q4 2026
Acutaas Chemicals has published its Q4 2026 annual report on April 30, 2026.
Acutaas Chemicals Transcript: Q3 25/26
Q3 FY 2026 saw revenue rise 43% year-over-year to INR 393.2 crore, with record-high margins and profit after tax exceeding INR 100 crore. Upgraded FY 2026 guidance projects 30% revenue growth and 32–35% EBITDA margin, driven by strong CDMO, battery, and semiconductor segments.
Acutaas Chemicals Quarterly report: Q3 2026
Acutaas Chemicals has published its Q3 2026 quarterly earnings report on January 28, 2026.
Acutaas Chemicals Slides: Q3 2026
Acutaas Chemicals has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on January 28, 2026.